25 related articles for article (PubMed ID: 23769056)
21. Mouse T cells engineered to display on their surface a novel form of FasL protein undergo apoptosis when stimulated with alloantigens: implications for graft-versus-host disease.
Yolcu ES; Singh NP
Transplant Proc; 2013 Jun; 45(5):1850-2. PubMed ID: 23769056
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
23. Cytokine dysregulation as a mechanism of graft versus host disease.
Ferrara JL
Curr Opin Immunol; 1993 Oct; 5(5):794-9. PubMed ID: 8240742
[TBL] [Abstract][Full Text] [Related]
24. Can antigen-specific regulatory T cells protect against graft versus host disease and spare anti-malignancy alloresponse?
Pidala J; Anasetti C
Haematologica; 2010 Apr; 95(4):660-5. PubMed ID: 20015881
[TBL] [Abstract][Full Text] [Related]
25. Fas Ligand-Modified Scaffolds Protect Stem Cell Derived β-Cells by Modulating Immune Cell Numbers and Polarization.
Li F; Crumley K; Bealer E; King JL; Saito E; Grimany-Nuno O; Yolcu ES; Shirwan H; Shea LD
ACS Appl Mater Interfaces; 2022 Dec; ():. PubMed ID: 36533683
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]
